Upcoming Virtual Workshops

Apply to join us at our next meeting in...


Optimizing Gene Therapy Manufacturing: Reducing Toxicity and Ensuring Safety

What: A virtual workshop, senior level only. No fee to register your interest and attend the meeting. Please be aware this is part of a subscription solution.

When & where: May 23, 2023 | 4PM BST | Digital meeting

Topic: Safety is a key concern for gene therapy. Managing toxicity and safety through developing best practices is a shared challenge for the whole industry, this meeting will help lay out a road map for safety and best practice regarding manufacturing.

Why: The event is driven by interactions between participants and promotes the candid exchange of information between companies. Only senior-level execs are invited. You will make high-quality new connections and learn from peers about best practices.

Audience: Senior gene therapy leaders from across the life sciences industry

Format: TBC

Meeting contributors:

  • Ned Finn, Executive Director of Gene Therapy, BCBSA 
  • David Dobnik, Researcher, NIB (Slovenia) 
  • Guest speaker: Dr J Fraser Wright, Founder, Kriya Tx

We have a limited number of trial places available at this meeting for professionals from biotech or pharma companies. If you would value the opportunity to see how a Gene Therapy for Rare Disorders: Searchlight subscription can help you, apply to join this meeting.

An Opportunity to Engage with Gene Therapy Leaders from the likes of: